The effect of peptides on cerebrovascular resistance in cats.
Wahl
M
M
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002216:Captopril / Q000494:pharmacology; D002415:Cats; D002536:Cerebral Arteries / Q000187:drug effects*; D004745:Enkephalins / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009496:Neurotensin / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004745:Enkephalins; D010455:Peptides; D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D009270:Naloxone; D009496:Neurotensin; D009020:Morphine; D002216:Captopril; D001920:Bradykinin